Annual Net Income
-$307.00 M
-$40.00 M-14.98%
December 31, 2023
Summary
- As of February 12, 2025, RCUS annual net profit is -$307.00 million, with the most recent change of -$40.00 million (-14.98%) on December 31, 2023.
- During the last 3 years, RCUS annual net income has fallen by -$184.00 million (-149.59%).
- RCUS annual net income is now -679.25% below its all-time high of $53.00 million, reached on December 31, 2021.
Performance
RCUS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$92.00 M
+$1.00 M+1.08%
September 30, 2024
Summary
- As of February 12, 2025, RCUS quarterly net profit is -$92.00 million, with the most recent change of +$1.00 million (+1.08%) on September 30, 2024.
- Over the past year, RCUS quarterly net income has dropped by -$21.00 million (-29.58%).
- RCUS quarterly net income is now -132.91% below its all-time high of $279.54 million, reached on December 31, 2021.
Performance
RCUS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$270.00 M
-$21.00 M-8.43%
September 30, 2024
Summary
- As of February 12, 2025, RCUS TTM net profit is -$270.00 million, with the most recent change of -$21.00 million (-8.43%) on September 30, 2024.
- Over the past year, RCUS TTM net income has increased by +$23.00 million (+7.85%).
- RCUS TTM net income is now -439.46% below its all-time high of $79.54 million, reached on September 30, 2022.
Performance
RCUS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RCUS Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -15.0% | -29.6% | +7.8% |
3 y3 years | -149.6% | -29.6% | +7.8% |
5 y5 years | -519.0% | -29.6% | +7.8% |
RCUS Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -679.3% | at low | -132.9% | +1.1% | -439.5% | +12.1% |
5 y | 5-year | -679.3% | at low | -132.9% | +1.1% | -439.5% | +12.1% |
alltime | all time | -679.3% | at low | -132.9% | +1.1% | -439.5% | +12.1% |
Arcus Biosciences Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$92.00 M(-1.1%) | -$270.00 M(+8.4%) |
Jun 2024 | - | -$93.00 M(+2225.0%) | -$249.00 M(+7.8%) |
Mar 2024 | - | -$4.00 M(-95.1%) | -$231.00 M(-24.8%) |
Dec 2023 | -$307.00 M(+15.0%) | -$81.00 M(+14.1%) | -$307.00 M(+4.8%) |
Sep 2023 | - | -$71.00 M(-5.3%) | -$293.00 M(+2.1%) |
Jun 2023 | - | -$75.00 M(-6.3%) | -$287.00 M(+2.9%) |
Mar 2023 | - | -$80.00 M(+19.4%) | -$279.00 M(+4.5%) |
Dec 2022 | -$267.00 M(-603.8%) | -$67.00 M(+3.1%) | -$267.00 M(-435.7%) |
Sep 2022 | - | -$65.00 M(-3.0%) | $79.54 M(+19.5%) |
Jun 2022 | - | -$67.00 M(-1.5%) | $66.56 M(+15.6%) |
Mar 2022 | - | -$68.00 M(-124.3%) | $57.59 M(+8.7%) |
Dec 2021 | $53.00 M(-143.1%) | $279.54 M(-458.5%) | $53.00 M(-119.0%) |
Sep 2021 | - | -$77.97 M(+2.6%) | -$278.53 M(+40.2%) |
Jun 2021 | - | -$75.97 M(+4.7%) | -$198.74 M(+18.4%) |
Mar 2021 | - | -$72.59 M(+39.6%) | -$167.84 M(+36.5%) |
Dec 2020 | -$123.00 M | -$51.99 M(-2953.7%) | -$123.00 M(+40.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | $1.82 M(-104.0%) | -$87.60 M(-21.6%) |
Jun 2020 | - | -$45.07 M(+62.4%) | -$111.78 M(+17.9%) |
Mar 2020 | - | -$27.75 M(+67.2%) | -$94.79 M(+11.9%) |
Dec 2019 | -$84.71 M(+70.8%) | -$16.60 M(-25.7%) | -$84.71 M(+5.4%) |
Sep 2019 | - | -$22.35 M(-20.4%) | -$80.41 M(+16.8%) |
Jun 2019 | - | -$28.09 M(+59.0%) | -$68.87 M(+26.8%) |
Mar 2019 | - | -$17.67 M(+43.7%) | -$54.31 M(+9.5%) |
Dec 2018 | -$49.59 M(-6.6%) | -$12.29 M(+13.7%) | -$49.59 M(-1.8%) |
Sep 2018 | - | -$10.81 M(-20.1%) | -$50.51 M(-19.6%) |
Jun 2018 | - | -$13.53 M(+4.5%) | -$62.82 M(+6.8%) |
Mar 2018 | - | -$12.95 M(-1.9%) | -$58.84 M(+10.8%) |
Dec 2017 | -$53.08 M(+195.4%) | -$13.21 M(-42.9%) | -$53.08 M(+33.1%) |
Sep 2017 | - | -$23.12 M(+142.1%) | -$39.87 M(+138.0%) |
Jun 2017 | - | -$9.55 M(+32.6%) | -$16.75 M(+132.6%) |
Mar 2017 | - | -$7.20 M | -$7.20 M |
Dec 2016 | -$17.97 M | - | - |
FAQ
- What is Arcus Biosciences annual net profit?
- What is the all time high annual net income for Arcus Biosciences?
- What is Arcus Biosciences annual net income year-on-year change?
- What is Arcus Biosciences quarterly net profit?
- What is the all time high quarterly net income for Arcus Biosciences?
- What is Arcus Biosciences quarterly net income year-on-year change?
- What is Arcus Biosciences TTM net profit?
- What is the all time high TTM net income for Arcus Biosciences?
- What is Arcus Biosciences TTM net income year-on-year change?
What is Arcus Biosciences annual net profit?
The current annual net income of RCUS is -$307.00 M
What is the all time high annual net income for Arcus Biosciences?
Arcus Biosciences all-time high annual net profit is $53.00 M
What is Arcus Biosciences annual net income year-on-year change?
Over the past year, RCUS annual net profit has changed by -$40.00 M (-14.98%)
What is Arcus Biosciences quarterly net profit?
The current quarterly net income of RCUS is -$92.00 M
What is the all time high quarterly net income for Arcus Biosciences?
Arcus Biosciences all-time high quarterly net profit is $279.54 M
What is Arcus Biosciences quarterly net income year-on-year change?
Over the past year, RCUS quarterly net profit has changed by -$21.00 M (-29.58%)
What is Arcus Biosciences TTM net profit?
The current TTM net income of RCUS is -$270.00 M
What is the all time high TTM net income for Arcus Biosciences?
Arcus Biosciences all-time high TTM net profit is $79.54 M
What is Arcus Biosciences TTM net income year-on-year change?
Over the past year, RCUS TTM net profit has changed by +$23.00 M (+7.85%)